BioNote, Inc. (KRX: 377740)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,610.00
-10.00 (-0.22%)
Oct 14, 2024, 3:19 PM KST
5.98%
Market Cap 472.01B
Revenue (ttm) 95.08B
Net Income (ttm) 81.65B
Shares Out 102.06M
EPS (ttm) 798.94
PE Ratio 5.79
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 99,667
Open 4,610.00
Previous Close 4,620.00
Day's Range 4,545.00 - 4,640.00
52-Week Range 3,800.00 - 6,400.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 14, 2024

About BioNote

BioNote, Inc., manufactures and sells in-vitro diagnostic animal medicines in South Korea. It offers animal diagnostics products, such as fluorescence immunoassay, molecular diagnostics, clinical biochemistry, rapid immunoassay, and enzyme-linked immunosorbent assay products. The company also provides bio-content products, including rapid immunoassay for humans, human intermediate goods, and bio-contents reagents. In addition, it engages in the production and sell of medical devices. BioNote, Inc. was founded in 2003 and is headquartered in Hwa... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2003
Employees 298
Stock Exchange Korea Stock Exchange
Ticker Symbol 377740
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.